Sizing up the GLP race
The Daily Brief
00:00
Intro
This chapter explores the potential of GLP-1 drugs like semaglutide, focusing on Indian pharmaceutical companies preparing to enter the market. It discusses the complexities of drug production and the challenges posed by patent expirations, highlighting the competitive landscape ahead.
Transcript
Play full episode
